ReviewCardiovascular & hematological disorders drug targets2025

Ranolazine: An Established Anti-anginal Drug with Emerging Antidiabetic Potential Supported by Preclinical and Clinical Evidence.

Konstantinos N Tentolouris et al.PubMed ↗Publisher ↗

No numbers read from the abstract.